AstraZeneca PLC's Nasal Flu Vaccine, Fluenz Gets European Medicines Evaluation Agency's Backing For Kids
LONDON, Oct 22 (Reuters) - AstraZeneca's (AZN.L) nasal flu vaccine has been recommended for approval in Europe, initially for children, although it is unlikely to go on sale until 2012.